验证数据展示
Neutralization |
产品信息
69010-1-Ig targets NeutraKine® Noggin in ELISA, Neutralization applications and shows reactivity with Human samples.
经测试应用 | ELISA, Neutralization Application Description |
经测试反应性 | Human |
免疫原 | human Humankine Noggin protein HZ-1118 种属同源性预测 |
宿主/亚型 | Mouse / IgG1 |
抗体类别 | Monoclonal |
产品类型 | Antibody |
全称 | noggin |
别名 | NeutraKine® Noggin, NOG, noggin, SYM1, SYNS1 |
基因名称 | Noggin |
Gene ID (NCBI) | 9241 |
RRID | AB_2882928 |
偶联类型 | Unconjugated |
形式 | Lyophilized Powder |
纯化方式 | Protein G purification |
储存缓冲液 | Sterile PBS , pH 7.4 |
内毒素 | <0.1 EU/μg |
复溶 | This product was lyophilized from a 0.2 μm filtered solution in PBS. Reconstitute at 1.0 mg/mL in sterile H2O before use. |
稳定性与储存 | Lyophilized antibodies are stable for 1 year from the date of receipt if stored between (-20°C) and (-80°C). Upon reconstitution we recommend that the solution can be stored at (4°C) for short term or at (-20°C) to (-80°C) for long term. Repeated freeze thaw cycles should be avoided with reconstituted products. |
背景介绍
Noggin is an extracellular polypeptide acting as an antagonist of bone morphogenetic proteins (BMPs) regulating embryonal development. Noggin inhibits activity of BMP-2, -4, -7, -13, and -14. Noggin is present extracellularly in the matrix or retained at the cell surface via interaction with heparin sulfate proteoglycans. In early development stages, Noggin is produced by the Spemann organizer, allowing dorsal-ventral patterning of BMPs (PMID: 8752214). Subsequently, Noggin is expressed by the notochord regulating BMP-4 signaling in neurogenesis. Additionally, Noggin is present during development in the dermal papilla, connective tissue of the hair follicle, lens, retina, and periocular mesenchyme, as well as in the mesoderm lineage regulating development of the bone, cartilage, and muscles.
This antibody can be used to neutralize the bioactivity of Noggin.
实验方案
Product Specific Protocols | |
---|---|
FC protocol for NeutraKine® Noggin antibody 69010-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |